State of the Art Symposium

SA 15 - Immunotherapy for cancer: do patients need targeted imaging?

July 15, 14:00 - 15:30 CEST

SA 15-1
5 min
Chairperson's introduction
Vicky J. Goh, London / UK
SA 15-2
18 min
Immunotherapy: an oncologist's view
Dirk De Ruysscher, Maastricht / Netherlands
1. To understand the clinical need for immunotherapies.
2. To summarise the different types and mechanisms of action of immunotherapy.
3. To describe the mechanisms for response and resistance.
SA 15-3
18 min
Standard imaging: limitations in assessing immunotherapy?
Clarisse Dromain, Lausanne / Switzerland
1. To summarise the different patterns of disease response to immunotherapy.
2. To describe the current response criteria for assessing immunotherapy.
3. To discuss the strengths and limitations of standard imaging for assessing immunotherapy.
SA 15-4
18 min
Molecular and hybrid imaging: what should we target?
1. To list the different possible targets for molecular imaging of immunotherapy.
2. To discuss the strengths and limitations of each technique.
3. To consider how targeted imaging may assist patient care.
SA 15-5
18 min
Predicting response to cancer immunotherapy using radiomics and artificial intelligence
Stefano Trebeschi, Amsterdam / Netherlands
1. To describe the key concepts in radiomics and artificial intelligence.
2. To understand how radiomics and artificial intelligence may contribute to response assessment.
3. To consider how radiomics and artificial intelligence may improve patient risk stratification.
SA 15-6
13 min
Panel discussion: Is targeted imaging and artificial intelligence the way forward to personalising cancer care with immunotherapy?